https://orcid.org/0000-0002-9486-9473
References
- Kato H, Kurosawa T, Horikawa K, Kimura Y, Miyakawa K, Ryo A, Goto A. Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects. Hum Vaccin Immunother. 2023 Dec 15;19(3):2278376. doi:10.1080/21645515.2023.2278376. Epub 2023 Nov 16.
- Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M. GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022 Aug 29;13:932043. doi:10.3389/fgene.2022.932043.
- Joob B, Wiwanitkit V. Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020 Mar;53(2):70. doi:10.3961/jpmph.20.065.
- Sookaromdee P, Wiwanitkit V. The expected seroprotection rate after the sixth dose of the COVID-19 vaccine: a note from a clinical model on kidney transplant recipients. İstanbul Tıp Fakültesi Dergisi. 2022;85(4):585–2. doi:10.26650/IUITFD.1133431.